Correlation Between Dynavax Technologies and Editas Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Editas Medicine, you can compare the effects of market volatilities on Dynavax Technologies and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Editas Medicine.

Diversification Opportunities for Dynavax Technologies and Editas Medicine

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dynavax and Editas is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Editas Medicine go up and down completely randomly.

Pair Corralation between Dynavax Technologies and Editas Medicine

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 3.33 times less return on investment than Editas Medicine. But when comparing it to its historical volatility, Dynavax Technologies is 3.5 times less risky than Editas Medicine. It trades about 0.11 of its potential returns per unit of risk. Editas Medicine is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  127.00  in Editas Medicine on November 1, 2024 and sell it today you would earn a total of  10.00  from holding Editas Medicine or generate 7.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  Editas Medicine

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
Editas Medicine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dynavax Technologies and Editas Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and Editas Medicine

The main advantage of trading using opposite Dynavax Technologies and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.
The idea behind Dynavax Technologies and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing